Case Western Reserve University
Cleveland, Ohio, 44109, United States
NCT Number: NCT01807793
Stroke is the leading cause of disability, third leading cause of death, and one of the most resource-intensive diseases among Americans. African-Americans (AA) have a stroke rate nearly double that of Euro-Americans (EA), and AA who experience a first-ever stroke are younger, have greater stroke disability, more post-stroke complications, and slower recovery compared to EA.
Looking for future studies?
Notify Me22 year–64 year
Male
Interventional
Not applicable
Cleveland, Ohio, 44109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Screening/baseline, 3 months, 6 months
The primary outcome will be change in medication treatment adherence with stroke risk reduction pharmacotherapies as measured by the Tablets Routines Questionnaire (TRQ)
Time frame: Baseline, 3 months, 6 months
Secondary outcomes are changes in biologic parameters of stroke risk (blood pressure, HbA1c, BMI, cholesterol and triglycerides) and in health behaviors (diet, exercise, smoking, substance use) using standardized instruments
Case Western Reserve University
Other
Targeted Management Intervention for African-American Men With TIA or Stroke.
Acronym: TEAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02341664
Angina, Angina Pectoris
Little Rock, Arkansas, United States
View Trial DetailsNCT02008604
Brain Diseases, Brain Ischemia
Berlin, Germany
View Trial DetailsNCT01445613
Amaurosis Fugax, Blindness
Santa Clara, California, United States
View Trial DetailsNCT06943586
Brain Diseases, Brain Ischemia
Birmingham, Alabama, United States
View Trial Details